- Home
- EQX vs ARWR Comparison
EQX vs ARWR Comparison
Compare EQX & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EQX | ARWR |
|---|---|---|
| Founded | 2007 | 2003 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9B | 9.6B |
| IPO Year | N/A | 1993 |
Fundamental Metrics
Financial Performance| Metric | EQX | ARWR |
|---|---|---|
| Price | $14.71 | $70.04 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | $17.00 | ★ $60.70 |
| AVG Volume (30 Days) | ★ 7.8M | 3.3M |
| Earning Date | 11-05-2025 | 11-25-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $2,296,356,000.00 | $829,448,000.00 |
| Revenue This Year | $78.78 | N/A |
| Revenue Next Year | $60.10 | N/A |
| P/E Ratio | $185.13 | ★ N/A |
| Revenue Growth | 85.65 | ★ 23258.15 |
| 52 Week Low | $4.95 | $9.57 |
| 52 Week High | $15.10 | $72.36 |
Technical Indicators
Market Signals| Indicator | EQX | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 68.32 | 76.76 |
| Support Level | $13.37 | $60.29 |
| Resistance Level | $14.36 | $72.36 |
| Average True Range (ATR) | 0.60 | 5.14 |
| MACD | 0.07 | 1.44 |
| Stochastic Oscillator | 86.79 | 92.98 |
Price Performance
Historical ComparisonAbout EQX Equinox Gold Corp.
Equinox Gold Corp is a mining company engaged in the operation, acquisition, exploration, and development of mineral properties, with a focus on gold. Equinox Gold has around seven operating gold mines and a clear plan to increase production by advancing the pipeline of growth projects. Geographically, the company operates in the United States, Mexico, and Brazil. The majority of its revenue is generated from Canada.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.